AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Hypertension Management for Type 2 Diabetes
This chapter explores the latest advances in glucose-lowering therapies, with a focus on SGLT2 inhibitors and GLP-1 receptor agonists for type 2 diabetes and hypertension. It highlights the cardiovascular and renal benefits of these treatments, alongside a discussion on the evolving role of renal denervation therapy.